Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dDxzCfbwocewpKqRfApw

  ADVERTISEMENT  
May 8, 2012
Sign upForwardArchiveAdvertise
 
News for Invasive/Interventional Cardiologists

SCAI SmartBrief Special Report:
A Preview of the SCAI Scientific Sessions

Beginning tomorrow, many of the greatest leaders in interventional cardiology will gather in Las Vegas to explore the field's latest clinical advances, discuss the biggest issues facing its practitioners and chart a course for the future.

Headlined by engaging keynotes and organized by theme to keep participants on track, the 2012 SCAI Scientific Sessions offer something for everyone. Topics range from congenital heart disease to TAVR. Also included are special resources, such as an imaging symposium and a variety of workshops tailored especially to physicians just beginning their careers in interventional cardiology.

This special edition of the SCAI SmartBrief offers a glimpse at the exciting week to come. Look for a follow-up report next Tuesday, May 15, recapping the conference.

  Clinical News 
  • Late-breaking clinical trials
    This year's program includes the following late-breaking clinical trials:
    • Modern Endovascular Management of Patients with Iliac Artery Disease: Results from the MOBILITY Trial, Dr. Michael Jaff, FSCAI
    • Final Results and Follow-Up of Robotically Enhanced Coronary Intervention: The PRECISE Multi-Center Pivotal Study, Dr. Giora Weisz
    • Safety and Efficacy of Ixmyelocel-T, An Expanded Patient-Specific Mixed Cell Therapy, in Dilated Cardiomyopathy, Dr. Timothy Henry, FSCAI
    LinkedInFacebookTwitterEmail this Story
  • CMS issues final TAVR reimbursement guidelines
    The CMS will cover transcatheter aortic valve replacement in severe cases of aortic stenosis if certain conditions are met, including use of an FDA-approved device and participation by interventional and surgical specialists. In addition, outcomes including stroke, all-cause mortality and quality of life must be noted. MedPage Today (free registration) (5/1) LinkedInFacebookTwitterEmail this Story
  • Study: Survival similar regardless of when PCI occurs
    High-volume cath labs should see similar primary PCI outcomes regardless of when the procedure occurs, according to a single-center study of more than 4,000 STEMI patients. The study compared the outcomes of procedures performed during regular business hours with those done at other times and on weekends. Mortality at 30 days, one year and four years was statistically similar among the groups. CardiovascularBusiness.com (5/3) LinkedInFacebookTwitterEmail this Story
  • Research fuels discussion on DES, bare-metal stents
    Researchers whose work compares the outcomes of treatment with bare-metal and first-generation drug-eluting stents say their work supports use of DES, but an accompanying commentary urges caution. Study authors wrote that DES were linked to a significant and sustained decrease in target vessel revascularization, while levels of cumulative stent thrombosis, reinfarction and death were similar. However, Dr. James Brophy wrote that levels of late reinfarction and very late stent thrombosis with DES were "worrisome." TheHeart.org (Montreal) (free registration) (4/26), Forbes (4/23) LinkedInFacebookTwitterEmail this Story
  Modern Health Care 
  • Town hall keynote: "This is a moment of opportunity"
    Dr. Elliot Fisher will issue a challenge to SCAI 2012 attendees in his talk "Why Interventional Cardiology Needs to be a Change Leader," which kicks off Friday's town hall discussion on the state of interventional cardiology. "As a specialty, interventional cardiology has led the way in evidence-based care and quality improvement," Fisher said. Presentations will focus on ways interventional cardiologists have worked to improve safety and quality, and the challenges ahead. An open discussion will follow. LinkedInFacebookTwitterEmail this Story
 
  • Appropriate use guidance in your pocket
    The SCAI Quality Improvement Toolkit session will include the debut of the SCAI-QIT AUC and Guidelines Application. Although not meant to serve as a substitute for clinical judgment, the app uses patient data to indicate whether a given case falls within appropriate use. The app includes the updated AUC for Coronary Revascularization, and other criteria are expected to be added. LinkedInFacebookTwitterEmail this Story
 
  • 5-part strategy helps reduce MI deaths, study says
    Hospitals that used a five-prong strategy reduced the risk of patient death 30 days after myocardial infarction by more than 1%, compared with facilities that did not use any of the methods, Yale University researchers reported in the Annals of Internal Medicine. The five elements were not cross-training ICU nurses for the cardiac catheterization lab, conducting monthly meetings for clinicians and transport staff, having a cardiologist always available, encouraging creative problem-solving by providers, and having both physician and nurse champions. MedPage Today (free registration) (4/30) LinkedInFacebookTwitterEmail this Story
  • Keeping cardiology services solvent: 5 trends to track
    Mike Vintges, a vice president with supply contracting firm Novation, says staying on top of technological advances, maintaining appropriate utilization and monitoring the impact of devices on patient outcomes are among the keys to keeping hospital cardiology departments in good financial shape. BeckersHospitalReview.com (4/24) LinkedInFacebookTwitterEmail this Story
  • Other News
  SCAI Highlights 
  • Key topics, key experts
    Past SCAI president Ted Feldman, M.D., FSCAI, delivers this year's Founders' Lecture with a focus on percutaneous valve therapies. "We're seeing the launch of the next generation of interventions in valve and structural heart disease," Dr. Feldman said. "These therapies are dramatic and important because we can treat patients with valve disease who previously had no options, and we can treat patients who have a surgical option without exposing them to open-heart surgery."

    ACC past president Ralph Brindis, M.D., FSCAI, delivers this year's Hildner Lecture posing tough questions on cardiology and appropriateness of care. "Dr. Brindis will challenge each of us to engage in self-reflection, to ask ourselves if we are doing the right things, using health care resources wisely, and being totally transparent," said program co-chair Kenneth Rosenfield, M.D., FSCAI.

    Julio C. Palmaz, M.D., in this year's Mullins Lecture discusses technological advances and their application in pediatric patients. "Congenital heart disease is one of the most critical, risky, and difficult challenges in medicine. People dedicated to treat children with these problems combine very hard work, resourcefulness, and passion. Chuck Mullins is the ultimate example of this, and I was lucky to share some early stent work in this area with him," Dr. Palmaz said.

    LinkedInFacebookTwitterEmail this Story
  • Staying on track at the conference
    This year's conference is organized by theme to keep participants on track.
 
  • Coronary Track: Highlights include a radial and chronic total occlusion symposia, sessions on complex PCI and treatment of bifurcations, and "Worst Nightmares and Best Saves." LinkedInFacebookTwitterEmail this Story
  • Peripheral Track: Best practices and techniques in peripheral vascular disease (PVD) and the year's greatest advances are on tap for this track. Other highlights include a symposium on critical limb ischemia and interactive sessions focused on complications and appropriate use. LinkedInFacebookTwitterEmail this Story
  • Structural Track: Tough calls, peculiar findings and common errors are among the highlights of this track. The track also features an imaging symposium and a mini symposium on transcatheter aortic valve replacement. LinkedInFacebookTwitterEmail this Story
  • Congenital Heart Disease Track: Are pre-mounted stents the best choice for children weighing seven to 10 kilograms? This track addresses that question and more, as well as featuring two "I Blew It!" sessions, imaging safety and more. LinkedInFacebookTwitterEmail this Story
  • Multidisciplinary Track: This track features board exam review sessions, the "Best of the Best Abstracts" and SCAI's Quality Improvement Toolkit. LinkedInFacebookTwitterEmail this Story
  • Early-Career Track: This track highlights events geared toward early-career interventionalists. Topics include how to build a clinical practice, forge an academic career, and gain a national reputation. LinkedInFacebookTwitterEmail this Story
  • Don't miss it!
    On-site registration will be available starting today at the Mirage from noon to 6 p.m.

    Keep up with SCAI 2012 on Twitter using the hashtag #SCAI2012.

    The SCAI 2012 app also allows attendees to thumb through abstracts, pull up faculty bios and photos, locate session rooms on the fly, get real-time updates to the schedule, and receive critical announcements. SCAI 2012 premium registrants will also be able to view SCAI 2012 On Demand content. Download the app for your iPad and iPhone here. LinkedInFacebookTwitterEmail this Story
 
  • Acknowledgments for support
    SCAI acknowledges the following for support of the conference:
    • PLATINUM: Abbott Vascular
    • GOLD: Boston Scientific
    • SILVER: AstraZeneca; Medtronic; The Medicines Company
    • BRONZE: Daiichi Sankyo, Inc. and Lilly USA, LLC; Cook Medical; Cordis Corporation, a Johnson & Johnson Company; St. Jude Medical, Inc.; Terumo Medical Corporation
    • SCAI also appreciates the educational grant support provided by Atrium Medical Corporation - a MAQUET Getinge Group company, Gilead Sciences and MEDRAD.
    LinkedInFacebookTwitterEmail this Story
  The Leaders' Corner 
  • A note from the program directors
    SCAI 2012 is going to be important. We hope you'll find that this is the most important meeting you will attend this decade with deep discussions about the value of interventional therapies for patients.

    It's going to be intense: thorough examination of how to prevent procedural complications and how to handle them when they develop.

    It's going to be inspiring: leaders in the field looking to the future of coronary, peripheral, structural, and congenital/pediatric cardiovascular care.

    And it's going to be fun. It's going to be the most interactive program we know of. Interventionalists are problem solvers. We are at our best when we're thinking creatively, which is why we're going to come together at SCAI 2012 to tackle some of the most challenging issues facing Interventional Cardiology and health care in general.

    Most sessions will be jointly moderated by experts at different stages of their careers who will facilitate dialogue among faculty and attendees. For example, in the "best practices" sessions, we're of course going to examine the "how to ..." of optimal techniques. But we're also going to ask questions about overall decision making, such as "Are we looking at the full range of options for this case?" and "Will performing the more expensive therapy also deliver the most value for the patient?"

    In short, your participation in SCAI 2012 will change how you approach clinical decisions.

    --James B. Hermiller, M.D., FSCAI
       Kenneth Rosenfield, M.D., FSCAI
       Program co-directors

    LinkedInFacebookTwitterEmail this Story
  
ADVERTISEMENT

Product announcements appearing in SmartBrief are paid advertisements and do not reflect actual SCAI endorsements. The news reported in SmartBrief does not necessarily reflect the official position of SCAI.
The news summaries appearing in SCAI SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI SmartBrief constitute the official opinion of SCAI.

The SCAI SmartBrief news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI SmartBrief may be directed to SmartBrief at scai@smartbrief.com.
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Aaron Kern (202) 407-7866
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent SCAI SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information